Close
Back to OCUL Stock Lookup

Ocular Therapeutix (OCUL) – Hot FDA News

Sep 27, 2022 09:14 AM UPDATE: Ocular Therapeutix (OCUL) Falls 14% After Reporting Interim 7-month Data from Phase 1 Clinical Trial of OTX-TKI
Oct 22, 2021 08:01 AM Ocular Therapeutix (OCUL) Phase 2 Clinical Trial of OTX-CSI for the Treatment of Dry Eye Disease Did Not Meet Primary Endpoint
Apr 28, 2020 07:07 AM
May 20, 2019 04:07 PM
Dec 3, 2018 07:01 AM
Jul 11, 2017 05:02 PM
Apr 24, 2017 12:35 PM
Jul 25, 2016 08:08 AM

Back to OCUL Stock Lookup